Key Insights

Highlights

Success Rate

86% trial completion

Published Results

17 trials with published results (15%)

Research Maturity

69 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.8%

11 terminated out of 112 trials

Success Rate

86.3%

-0.3% vs benchmark

Late-Stage Pipeline

11%

12 trials in Phase 3/4

Results Transparency

25%

17 of 69 completed with results

Key Signals

17 with results86% success11 terminated

Data Visualizations

Phase Distribution

80Total
Not Applicable (24)
Early P 1 (3)
P 1 (20)
P 2 (21)
P 3 (7)
P 4 (5)

Trial Status

Completed69
Terminated11
Recruiting10
Unknown9
Active Not Recruiting5
Not Yet Recruiting3

Trial Success Rate

86.3%

Benchmark: 86.5%

Based on 69 completed trials

Clinical Trials (112)

Showing 20 of 20 trials
NCT04128306Not ApplicableCompletedPrimary

Brain Areas of Time-To-Contact Perception: an Awake Surgery Study

NCT07274397Not ApplicableRecruiting

Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma

NCT07620470RecruitingPrimary

Spectral Precise Image Study for Brain Tumors

NCT01875601Phase 1Completed

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

NCT07599917Not Yet RecruitingPrimary

Diagnostic Performance and Quantitative Analysis of [18F]FET PET in Brain Tumours

NCT07595666Not ApplicableEnrolling By Invitation

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

NCT01115777Active Not RecruitingPrimary

Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies

NCT06810336Early Phase 1Recruiting

Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery

NCT07530536Not ApplicableRecruitingPrimary

rTMS for Postoperative Brain Tumor Patients

NCT00850278Not ApplicableCompleted

Assessment of [18F]FLT-PET Imaging for Diagnosis and Prognosis of Brain Tumors

NCT06878469Not ApplicableRecruitingPrimary

SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence

NCT06442748Phase 3Recruiting

Short Versus Long-term Levetiracetam in Brain Tumors

NCT00811148RecruitingPrimary

Florida Center for Brain Tumor Research

NCT07321262Completed

Machine Learning to Predict Postoperative Pneumonia in Brain Tumor Patients

NCT06322342Phase 2Completed

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

NCT02066220Phase 2Active Not RecruitingPrimary

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

NCT01117168Active Not Recruiting

Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group

NCT01849952Terminated

Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas

NCT02191488Phase 1Active Not RecruitingPrimary

ALA-induced PpIX Fluorescence During Brain Tumor Resection

NCT06390579Completed

Building Research With Artificial Intelligence in Neuro-Ophthalmology

Scroll to load more

Research Network

Activity Timeline